Plain-English translation of NCT06580002 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether a medication called can help improve thinking and memory problems that sometimes occur after cancer treatment or brain radiation. Researchers believe may work by increasing a natural brain chemical that supports brain health. The study will compare to a placebo (a dummy pill) in cancer survivors and patients who have received brain radiation.
Many cancer survivors experience thinking and memory problems—sometimes called 'chemo brain'—after their treatment ends, and there is no proven treatment for this problem yet. Researchers hope this medication might help restore brain function by supporting the brain's natural healing processes.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will take a pill twice a day (every 12 hours) for 8 weeks—either the actual medication or a placebo that looks identical. You will complete questionnaires and thinking tests (on a computer or on paper) at the start, during, and at the end of the 8 weeks to measure whether your memory and concentration improve. The study team will also measure a brain chemical in your blood to see if the medication is working as hoped.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
United States